175 related articles for article (PubMed ID: 26390161)
1. Current options for transfusion-related acute lung injury risk mitigation in platelet transfusions.
Dunbar NM
Curr Opin Hematol; 2015 Nov; 22(6):554-8. PubMed ID: 26390161
[TBL] [Abstract][Full Text] [Related]
2. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
3. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.
Andreu G; Boudjedir K; Muller JY; Pouchol E; Ozier Y; Fevre G; Gautreau C; Quaranta JF; Drouet C; Rieux C; Mertes PM; Clavier B; Carlier M; Sandid I
Transfus Med Rev; 2018 Jan; 32(1):16-27. PubMed ID: 28864336
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-related acute lung injury risk mitigation: an update.
Otrock ZK; Liu C; Grossman BJ
Vox Sang; 2017 Nov; 112(8):694-703. PubMed ID: 28948604
[TBL] [Abstract][Full Text] [Related]
6. Transfusion therapy and acute lung injury.
Sokolovic M; Pastores SM
Expert Rev Respir Med; 2010 Jun; 4(3):387-93. PubMed ID: 20524921
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-related acute lung injury: Current understanding and preventive strategies.
Vlaar AP
Transfus Clin Biol; 2012 Jun; 19(3):117-24. PubMed ID: 22682310
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-related acute lung injury (TRALI): a case report and literature review.
Donelan KJ; Anderson KA
S D Med; 2011 Mar; 64(3):85-8. PubMed ID: 21473518
[TBL] [Abstract][Full Text] [Related]
9. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
11. Preservation of recipient plasma sphingosine-1-phosphate levels reduces transfusion-related acute lung injury.
Hsing V; Zhao HQ; Post M; Devine D; McVey MJ
Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L589-L595. PubMed ID: 38375568
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of CD62P during storage of apheresis platelet concentrates and the role of CD62P in transfusion-related acute lung injury.
Tong S; Wang H; Zhang T; Chen L; Liu B
Mol Med Rep; 2015 Nov; 12(5):7777-81. PubMed ID: 26397744
[TBL] [Abstract][Full Text] [Related]
13. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
[TBL] [Abstract][Full Text] [Related]
14. Future preventive and therapeutic targets for transfusion-related acute lung injury.
Curtis BR
Curr Pharm Des; 2012; 18(22):3285-92. PubMed ID: 22621267
[TBL] [Abstract][Full Text] [Related]
15. The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil.
Blatyta PF; Custer B; Liu J; Mendrone-Junior A; Wright DJ; Leão SC; Lopes MI; Carneiro-Proietti AB; Sabino EC; de Almeida-Neto C;
Transfus Apher Sci; 2013 Feb; 48(1):15-20. PubMed ID: 22985535
[TBL] [Abstract][Full Text] [Related]
16. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis.
Müller MC; van Stein D; Binnekade JM; van Rhenen DJ; Vlaar AP
Transfusion; 2015 Jan; 55(1):164-75. PubMed ID: 25135630
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
Lin Y; Saw CL; Hannach B; Goldman M
Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
[TBL] [Abstract][Full Text] [Related]
18. Reducing transfusion-related acute lung injury risk: evidence for and approaches to transfusion-related acute lung injury mitigation.
Makar RS; Powers A; Stowell CP
Transfus Med Rev; 2012 Oct; 26(4):305-20. PubMed ID: 22520553
[TBL] [Abstract][Full Text] [Related]
19. State of the art management of transfusion-related acute lung injury (TRALI).
Goldberg AD; Kor DJ
Curr Pharm Des; 2012; 18(22):3273-84. PubMed ID: 22621274
[TBL] [Abstract][Full Text] [Related]
20. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
